Kaptopril Krka

Captopril, the active ingredient in Kaptopril Krka, is an ACE inhibitor presented as an oral tablet for oral use. It is indicated for use in patients with hypertension, congestive heart failure, after myocardial infarction, and in diabetic nephropathy to slow renal deterioration.

GNH USA supplies Kaptopril Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for importers. GNH USA’s global distribution network ensures timely delivery and compliance with local regulatory requirements.

Captopril acts on the renin‑angiotensin‑aldosterone system to lower blood pressure and improve cardiac outcomes.

Hypertension: reduces systemic vascular resistance and lowers arterial pressure. Congestive heart failure: decreases preload and afterload, improving cardiac output and symptoms. Post‑myocardial infarction: helps prevent ventricular remodeling and reduces mortality risk. Diabetic nephropathy: slows progression of kidney damage by lowering intraglomerular pressure.

Captopril may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Cough: dry, persistent cough. - Dizziness: light‑headedness, especially after initial doses. - Taste disturbances: metallic or altered taste.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure leading to fainting. - Neutropenia: significant reduction in white blood cells.

When prescribing captopril, clinicians should consider several safety measures to minimize risks.

- Monitor blood pressure: check regularly after initiation and dose changes. - Assess renal function: evaluate serum creatinine and potassium before and during therapy. - Avoid in patients with a history of angioedema: risk of recurrence is increased. - Use cautiously in diabetic patients: may affect renal perfusion. - Pregnancy and lactation: risk unknown; discuss benefits and risks with healthcare provider. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Captopril can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Aliskiren (in diabetic patients): combined use may increase risk of renal impairment and hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone, amiloride): may cause dangerous hyperkalemia. - Lithium: concurrent use can raise lithium levels and toxicity risk.

Moderate Interactions (Monitor Closely): - NSAIDs (ibuprofen, naproxen): may reduce antihypertensive effect and affect kidney function. - Thiazide diuretics: can enhance hypotensive effect and increase electrolyte disturbances. - ACE inhibitor with other antihypertensives (beta‑blockers, calcium channel blockers): may require dose adjustment and blood pressure monitoring.